Farley Capital’s Bausch Health BHC Stock Holding History

Farley Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17,000	Closed	-$244K	–	15
2017 Q3	$244K	Hold	17,000	–	–	0.27%	13
2017 Q2	$294K	Hold	17,000	–	–	0.33%	11
2017 Q1	$188K	Hold	17,000	–	–	0.23%	12
2016 Q4	$247K	Hold	17,000	–	–	0.33%	11
2016 Q3	$417K	Hold	17,000	–	–	0.55%	8
2016 Q2	$342K	Hold	17,000	–	–	0.53%	10
2016 Q1	$447K	Buy	+17,000	New	+$1.26M	0.63%	9
2015 Q3	–	Sell	-10,000	Closed	-$2.22M	–	14
2015 Q2	$2.22M	Hold	10,000	–	–	1.71%	8
2015 Q1	$1.99M	Hold	10,000	–	–	1.57%	7
2014 Q4	$1.43M	Hold	10,000	–	–	1.01%	9
2014 Q3	$1.31M	Buy	+10,000	New	+$1.19M	0.88%	7

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Farley Capital's BHC Position: Q4 2017 in Review

Farley Capital reduced its Bausch Health (BHC) stake by 81% in Q4 2017, selling an estimated $3.5M and leaving 51,725 shares worth $1.07M. The position accounts for 1.51% of the portfolio, ranked #6.

Farley Capital first reported a position in BHC in Q2 2013 and has held it in 19 quarters since. The position peaked at $44.8M in Q3 2014. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

Farley Capital held 51,725 shares of Bausch Health worth $1.07M as of Q4 2017.
Farley Capital sold 220,423 Bausch Health shares in Q4 2017, an estimated $3.5M.
Bausch Health made up 1.51% of Farley Capital's portfolio in Q4 2017, its #6 holding.
Farley Capital first reported a position in Bausch Health in Q2 2013 and has held it in 19 quarters since.
Farley Capital's Bausch Health position peaked at $44.8M in Q3 2014.
315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on Farley Capital's 13F filing for Q4 2017, filed 13 Feb 2018.